Viktoria Gribovskaya

Ms. Viktoria Gribovskaya

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 July 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
PBPolina Babenkova
Polina Babenkova
AGArtem P. Gureev
Artem P. Gureev
ISIrina Sadovnikova
Irina Sadovnikova
IBInna Burakova
Inna Burakova
YDYuliya Dmitrievna Dvoretskaya
Yuliya Dmitrievna Dvoretskaya
MSMikhail Syromyatnikov
Mikhail Syromyatnikov
L-carnitine and Mildronate are substances that can significantly rearrange the energy metabolism of cells. This can potentially cause changes in the bacterial composition of the gut microbiome and affect testis functionality and male sexual health. Mice of the C57Bl/6 line were used. Sexual behavior was assessed using physiological tests, and gene expression patterns were assessed by qPCR. High-throughput sequencing of mouse fecal microbiota was performed. We showed that long-term administration of Mildronate has no significant effect on the intestinal microbiome, and there was a compensatory increase in the expression of genes involved in fatty acid and leptin metabolism. No impairment of sexual motivation in male mice was observed. Prolonged L-carnitine supplementation caused a decrease in alpha diversity of bacteria and a decrease in some groups of microorganisms that are components of a healthy gut microflora. A correlation was observed between the level of bacteria from Firmicutes phylum, indicators of sexual motivation of mice, and the dynamics of body weight gain. Our results may indicate that metabolic modulators can have a significant impact on the structure of the bacterial community of the gut microbiome, which may influence male sexual health through the gut–semen axis.

29 September 2026 in Current Neuropharmacology
Verified
Journal Article
Closed access
PDF file
VNVeronika Nesterova
Veronika Nesterova
DADianna Adzhemian
Dianna Adzhemian
VGViktoria Gribovskaya
Viktoria Gribovskaya
PBPolina Babenkova
Polina Babenkova
MIMikhail Ivanov
Mikhail Ivanov
Denis N. SilachevDenis N. Silachev
Denis N. Silachev
Introduction: Traumatic brain injury (TBI) frequently results in persistent cognitive deficits driven by secondary mechanisms including mitochondrial dysfunction, oxidative stress, and neuroinflammation. We compared the effects of L-carnitine and mildronate on spatial memory recovery after TBI and investigated the underlying cellular mechanisms. Methods: Male C57BL/6 mice were subjected to controlled cortical impact TBI and assigned to naïve, sham, TBI+saline, TBI+mildronate (100 mg/kg/day), or TBI+L-carnitine groups. Spatial working memory was evaluated using the Morris water maze over 21 days. At 24 days post-injury, we measured cortical and hippocampal malondialdehyde (MDA), mtDNA integrity and copy number, expression of genes related to mitochondrial biogenesis, glucose metabolism, angiogenesis, and neuroinflammation, and performed blood cytology. Results: TBI induced significant memory deficits, elevated MDA, and reduced mtDNA copy number without increased damage. Mildronate, but not L-carnitine, significantly improved cognitive performance. Mildronate upregulated Tfam, Glut4, Cd34, and Eng while downregulating Gfap in the hippocampus. Both compounds decreased MDA and circulating cell-free mtDNA. Discussion: Mildronate’s superior neuroprotection appears to involve enhanced mitochondrial biogenesis, glucose transport, and angiogenesis, alongside suppression of astrogliosis. In contrast, L-carnitine showed limited cognitive benefit, possibly due to insufficient mitochondrial renewal and vascular repair. Conclusion: Mildronate exerts greater neuroprotective effects than L-carnitine after TBI, likely via coordinated restoration of mitochondrial quality control, glucose utilization, and vascular remodeling, offering a promising strategy to mitigate post-traumatic cognitive decline.

Verified
Journal Article
Open access
PDF file
VGViktoria Gribovskaya
Viktoria Gribovskaya
DADianna Adzhemian
Dianna Adzhemian
PRPavel Denisovich Rogozin
Pavel Denisovich Rogozin
VNVeronika Nesterova
Veronika Nesterova
AGArtem Gureev
Artem Gureev
Denis N. SilachevDenis N. Silachev
Denis N. Silachev
Many widely used open-head models of traumatic brain injury (TBI) require craniotomy before injury, while sham-operated animals undergo surgery without impact and serve as controls. However, sham surgery itself may alter physiological, molecular, and behavioral parameters, complicating interpretation of TBI-specific effects. This narrative review, based on a structured PubMed search, synthesizes studies employing a three-group design to distinguish injury-related changes from those associated with craniotomy and other perioperative procedures. Evidence indicates that sham surgery produces outcome-, region-, and time-dependent effects that are generally milder, more localized, and more transient than TBI. These include neuroinflammatory responses, localized neuronal alterations, temporary sensorimotor and cognitive deficits, nociceptive changes, and shifts in gut microbiota. In contrast, TBI causes more severe abnormalities, including extensive neuronal damage, sustained astrogliosis, microglial activation, neutrophilic infiltration, mitochondrial dysfunction, and long-term dysbiosis. Most electrophysiological parameters are relatively unaffected by sham surgery, although selected changes have been reported. Importantly, differences between naïve and sham animals cannot be attributed exclusively to craniotomy, as anesthesia, analgesia, and surgical technique may contribute. Thus, sham surgery should not be considered a biologically neutral control. Inclusion of both naïve and sham groups is particularly important when distinguishing surgery-associated from injury-specific effects in preclinical studies.